WHAT IS THIS MEDICINE AND WHAT IS IT USED FOR?
Nucala contains mepolizumab, a biological medicine (a medicine made from
living cells) that targets a specific protein in the immune system called
interleukin-5 (IL-5).
IL-5 is a signalling molecule that drives the production and survival of
eosinophils — a type of white blood cell that is central to the inflammation
underlying certain severe forms of asthma and other conditions.
By blocking IL-5, mepolizumab reduces eosinophil levels in the blood and
airways, which in turn reduces inflammation, makes asthma easier to control,
and significantly reduces the risk of serious asthma attacks (called
exacerbations).
Your specialist may prescribe Nucala for: severe eosinophilic asthma —
uncontrolled despite high-dose inhaled medicines and other treatments, where
blood eosinophil counts are elevated; eosinophilic granulomatosis with
polyangiitis (EGPA — a rare autoimmune condition causing inflammation of blood
vessels, previously called Churg-Strauss syndrome); and hypereosinophilic
syndrome (HES — a rare condition of persistently very high eosinophil counts
causing organ damage).
3. HOW TO TAKE THIS MEDICINE
For severe asthma and EGPA: 100mg injected under the skin (subcutaneous
injection) once every 4 weeks (once a month).
For HES: 300mg (three 100mg injections at separate sites) once every 4
weeks. The injection is given by a healthcare professional in a clinic, or you
or a carer may be trained to self-inject at home after proper training. Inject
into the upper arm, thigh, or abdomen. Rotate injection sites.
Nucala is a long-term add-on treatment — it does not replace your
existing inhalers. Continue all your regular asthma inhalers and medicines as
prescribed. Nucala reduces the frequency and severity of asthma attacks over
time, but it is not a rescue inhaler and will not provide immediate relief
during an acute attack. Always keep your reliever inhaler (usually
salbutamol/albuterol) with you at all times.
⚠ PATIENT TIP: Take Nucala out of the fridge
about 30 minutes before injecting to allow it to warm to room temperature —
this makes the injection more comfortable. Do not try to speed this up by
heating it. After injecting, apply gentle pressure to the site for a few
seconds but do not rub it.
4. POSSIBLE SIDE EFFECTS
|
How Common? |
Side Effects |
|
Common |
Headache, back pain,
injection site reactions (redness, swelling, itching, or pain at the
injection site), fatigue, urinary tract infections, upper respiratory tract
infections (colds), nasal congestion |
|
Less Common |
Allergic reactions
(rash, hives, flushing) |
|
Serious — Seek
Emergency Help |
Anaphylaxis (severe
allergic reaction): difficulty breathing, throat swelling, dizziness,
collapse — seek emergency care immediately. This is rare but can occur within
minutes to hours of injection. Herpes zoster (shingles) reactivation — if you
develop a painful blistering rash, contact your doctor promptly. |
5. WHO SHOULD NOT TAKE THIS MEDICINE
Nucala should not be used during an acute asthma attack or for acute
worsening of asthma — it is a preventative medicine, not a rescue treatment. It
should not be used in people with known hypersensitivity to mepolizumab.
Use with caution in people with pre-existing helminth (parasitic worm)
infections, as blocking IL-5 may reduce the body's ability to fight these
parasites. Pregnancy and breastfeeding: discuss with your specialist — limited
data available.
⚠ NOT A RESCUE INHALER: Nucala prevents asthma
attacks over time but cannot stop an attack that is already happening. Always
keep your reliever (blue) inhaler with you. If you have a severe asthma attack,
use your reliever and call emergency services if it does not improve.
⚠ DO NOT STOP OTHER MEDICINES: Do not reduce or
stop your inhalers, oral steroids, or other asthma medicines without your
specialist's guidance — even if your asthma feels much better on Nucala.
Changes to your medicines should only be made under medical supervision.
⚠ ANAPHYLAXIS RISK: Although rare, a severe
allergic reaction can occur. The injection is usually given in a clinical
setting where you can be observed for 30 to 60 minutes afterwards. Report any
new rash, breathlessness, or throat tightening immediately.
6. MEDICINES THAT INTERACT WITH THIS TREATMENT
No significant drug interactions have been identified with mepolizumab.
It is a biological medicine targeting a specific immune pathway and does not
interact with most conventional medicines. However, always tell your
respiratory specialist and pharmacist about all medicines you take, including
over-the-counter products and other biological medicines.
7. HOW TO STORE THIS MEDICINE
Store in a refrigerator at 2–8°C. Do not freeze or shake. Protect from
light. Once removed from the fridge, allow to reach room temperature before use
(approximately 30 minutes). Use within the time specified after removal from
fridge. Keep out of reach of children.
8. PRESCRIPTION REQUIREMENT
|
Field |
Details |
|
Status |
Prescription Only
Medicine (POM) — Specialist (respiratory medicine / immunology) prescription
required; usually requires formal eligibility criteria review for severe
asthma (e.g. elevated blood eosinophil count) |
9. GUIDANCE FOR PATIENTS & CAREGIVERS
Nucala is given as a monthly injection under the skin — either in clinic
or at home once you are trained. Remove from the fridge 30 minutes before
injecting and allow to warm to room temperature.
Continue all your regular inhalers and medicines as prescribed — Nucala
works alongside them, not instead of them. Always carry your reliever inhaler
with you. After each injection, check the site for any unusual swelling or
reaction and report it. Attend all monthly injection appointments — consistency
is important for the medicine to work. If you notice your asthma worsening
between injections, contact your respiratory team promptly.
10. PHARMACIST & PRESCRIBER NOTES
|
Field |
Details |
|
Clinical Dispensing
Notes |
Biological anti-IL-5
monoclonal antibody — confirm eligibility criteria before dispensing
(eosinophil count threshold met, confirmed severe eosinophilic asthma
uncontrolled on existing therapy). Cold chain: 2–8°C; do not freeze or shake.
Allow to reach room temperature 30 minutes before injection. Self-injection
training documentation must be confirmed before home supply. Anaphylaxis risk
— first injection in supervised clinical setting recommended; anaphylaxis kit
available. Counsel explicitly: Nucala is preventative, not acute rescue —
reliever inhaler must be maintained at all times. Steroid sparing is a
treatment goal — do not discontinue oral corticosteroids abruptly; taper
under specialist guidance. Monthly injection schedule adherence counselling.
Helminth infection screening in patients from endemic areas. |
11. FREQUENTLY ASKED QUESTIONS
Q: Will Nucala replace my inhalers?
No — Nucala works alongside your inhalers, not instead of them. Keep
using all your regular inhalers as prescribed. Over time, your specialist may
be able to reduce your steroid tablets if your asthma improves, but this will
be done gradually and only under supervision.
Q: How long before I notice it working?
Many patients notice fewer asthma attacks and improved day-to-day
breathing within the first 3 to 6 months. Some improvement in symptoms can be
noticed earlier, but give it time — biological medicines like mepolizumab build
their effect gradually.
Q: Can I inject it myself at home?
Yes — once you have been trained by a nurse and are comfortable with the
technique, home self-injection is an option. Your specialist team will organise
training before setting you up for home injections.
Q: What do I do if I have an asthma attack between injections?
Use your reliever (blue) inhaler immediately. If it is not working, call
emergency services. Nucala prevents attacks, but cannot stop one that is already
happening — your reliever inhaler is still essential.
Q: How long will I need to take Nucala?
Severe eosinophilic asthma is a long-term condition, and most patients
benefit from ongoing mepolizumab treatment. Your specialist will review whether
the medicine is still working and needed at regular intervals.
There are no product reviews yet.